The calcineurin inhibitor and the intensity of the conditioning regimen may affect the occurrence of polyomavirus-associated hemorrhagic cystitis after haploidentical hematopoietic stem cell transplantation with post-transplant cyclophosphamide

被引：0
|
作者：
A Rimondo
R Crocchiolo
J El-Cheikh
S Bramanti
A Granata
S Furst
B Sarina
L Morabito
R Devillier
S Harbi
B Mohty
R Mineri
C Faucher
C Chabannon
A Santoro
D Blaise
L Castagna
机构：
[1] Humanitas Cancer Center,Department of Hematology
[2] Istituto Clinico Humanitas,undefined
[3] Oncology-hematology,undefined
[4] Bone Marrow Transplantation Program,undefined
[5] American University of Beirut,undefined
[6] Transplantation Program,undefined
[7] Institut Paoli Calmettes,undefined
[8] Molecular Biology Section,undefined
[9] Clinical Investigation Laboratory,undefined
[10] Istituto Clinico Humanitas,undefined
[11] Cell Therapy Unit,undefined
[12] Institut Paoli Calmettes,undefined
[13] Aix-Marseille Université,undefined
[14] Centre de Recherche en Cancérologie de Marseille (CRCM),undefined
来源：
Bone Marrow Transplantation | 2017年 / 52卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：135 / 137
页数：2
相关论文
共 50 条
  • [21] Impact of Early Immune Reconstitution after Haploidentical Stem Cell Transplantation with Post-Transplant Cyclophosphamide
    Dorado, Nieves
    Perez-Corral, Ana
    Kwon, Mi
    Solan, Laura
    Bailen, Rebeca
    Pascual, Cristina
    Serrano, David
    Anguita, Javier
    Balsalobre, Pascual
    Martinez-Laperche, Carolina
    Luis Diez-Martin, Jose
    [J]. BLOOD, 2018, 132
  • [22] HLA-Haploidentical Peripheral Blood Stem Cell Transplantation with Post-Transplant Cyclophosphamide after Busulfan-Containing Reduced-Intensity Conditioning
    Sugita, Junichi
    Kawashima, Naomi
    Fujisaki, Tomoaki
    Kakihana, Kazuhiko
    Ota, Shuichi
    Matsuo, Keitaro
    Miyamoto, Toshihiro
    Akashi, Koichi
    Taniguchi, Shuichi
    Harada, Mine
    Teshima, Takanori
    [J]. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2015, 21 (09) : 1646 - 1652
  • [23] Cytomegalovirus Reactivation after Allogeneic Hematopoietic Stem Cell Transplantation with Post-Transplant Cyclophosphamide
    Hebert, Courtney
    Watts, Nicole
    Isaac, Shiney
    Kukkamalla, Rivvi
    Jamy, Omer
    Saad, Ayman
    [J]. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2017, 23 (03) : S276 - S277
  • [24] Myeloablative and reduced-intensity conditioning in HLA-haploidentical peripheral blood stem cell transplantation using post-transplant cyclophosphamide
    Junichi Sugita
    Yusuke Kagaya
    Toshihiro Miyamoto
    Yasuhiko Shibasaki
    Koji Nagafuji
    Shuichi Ota
    Tatsuo Furukawa
    Miho Nara
    Koichi Akashi
    Shuichi Taniguchi
    Mine Harada
    Keitaro Matsuo
    Takanori Teshima
    [J]. Bone Marrow Transplantation, 2019, 54 : 432 - 441
  • [25] Myeloablative and reduced-intensity conditioning in HLA-haploidentical peripheral blood stem cell transplantation using post-transplant cyclophosphamide
    Sugita, Junichi
    Kagaya, Yusuke
    Miyamoto, Toshihiro
    Shibasaki, Yasuhiko
    Nagafuji, Koji
    Ota, Shuichi
    Furukawa, Tatsuo
    Nara, Miho
    Akashi, Koichi
    Taniguchi, Shuichi
    Harada, Mine
    Matsuo, Keitaro
    Teshima, Takanori
    [J]. BONE MARROW TRANSPLANTATION, 2019, 54 (03) : 432 - 441
  • [26] OVERVIEW OF POST-TRANSPLANT MONITORING IN PATIENTS AFTER HAPLOIDENTICAL ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION
    Cechova, Hana
    Pegova, Kristyna
    Pavlatova, Lucie
    Zizkova, Radka
    Hrabakova, Pavla
    Prerovska, Renata
    Stankova, Martina
    Brezinova, Dagmar
    [J]. HLA, 2018, 91 (05) : 403 - 404
  • [27] Hematopoietic Recovery and Transfusion Needs after Haploidentical Stem Cell Transplantation with Post-Transplant Cyclophosphamide in Adult Patients with Hematologic Malignancies
    Mohty, Razan
    Malard, Florent
    Ruggeri, Annalisa
    Brissot, Eolia
    Dulery, Remy
    Battipaglia, Giorgia
    Giannotti, Frederica
    Sestili, Simona
    Mediavilla, Clemence
    Mohty, Mohamad
    [J]. BLOOD, 2018, 132
  • [28] Increased early mortality after fludarabine and melphalan conditioning with peripheral blood grafts in haploidentical hematopoietic cell transplantation with post-transplant cyclophosphamide
    Eastburg, Luke
    Russler-Germain, David A.
    DiPersio, John F.
    Fountaine, Thomas
    Andolina, Jeffrey R.
    Abboud, Ramzi
    Huselton, Eric
    [J]. LEUKEMIA & LYMPHOMA, 2022, 63 (01) : 222 - 226
  • [29] Haploidentical Hematopoietic Stem Cell Transplant For Sickle Cell Disease Using Thiotepa Based Reduced Intensity Conditioning And Post Transplant Cyclophosphamide
    Kharya, D. G.
    Doval, D.
    Chaudhary, D. R.
    Dhamija, M.
    Khandelwal, V.
    Lunkad, S.
    Setia, R.
    Handoo, A.
    Sharma, S.
    Dadu, T.
    [J]. BONE MARROW TRANSPLANTATION, 2015, 50 : 5556 - 5557
  • [30] Haploidentical hematopoietic stem cell transplantation with post-transplant cyclophosphamide for patients with high-risk hematologic malignancies
    Carella, A. M.
    [J]. BONE MARROW TRANSPLANTATION, 2017, 52 : S183 - S184
12345